HZNP - Horizon Therapeutics Plc
IEX Last Trade
104.06
2.920 2.806%
Share volume: 3,831,115
Last Updated: Tue 08 Aug 2023 09:59:57 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$101.14
2.92
2.89%
Summary score
73%
Profitability
100%
Dept financing
29%
Liquidity
38%
Performance
65%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2019 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
3.9%
Return on assets
1.74%
Return on sales
14.68%
Return on invested capital
4.52%
Total debt ratio
45.85%
Debt ratio change over timeo
-6.52%
Current Ratio
3.12%
Quick Ratio
2.93%
Cash Position Ratio
1.82%
Short-term ratios 30-Jun-2022 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
2.13%
Return on assets
1.45%
Return on sales
14.28%
Return on invested capital
2.4%
Total debt ratio
43.71%
Debt ratio change over timeo
19.72%
Current Ratio
4.04%
Quick Ratio
3.85%
Cash Position Ratio
2.56%
Last quarter ratios 30-Jun-2023
The data are presented for the financials results of the last quarter.
Return on equity
2.39%
Return on assets
1.51%
Return on sales
14.9%
Return on invested capital
2.85%
Total debt ratio
42.89%
Debt ratio change over time
14.05%
Current Ratio
4.27%
Quick Ratio
4.09%
Cash Position Ratio
2.69%
Performance ratios (change over 4 years) 30-Jun-2019 - 30-Jun-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
120.52%
Return on assets
-101.57%
Return on sales
-75.55%
Return on invested capital
125.91%
Total debt ratio
-651.64%
Debt ratio change over time
-6.52%
Current Ratio
27.31%
Quick Ratio
25.18%
Cash Position Ratio
18.06%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HZNP | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 3.9% | 0% | 0% | -106.57% |
| Return on assets | 1.74% | 0% | 0% | -12.17% |
| Return on sales | 14.68% | 0% | 0% | -8133.27% |
| Return on invested capital | 4.52% | 0% | 0% | -41.1% |
| Profitability | 100% | 0% | 0% | 0% |
| Total debt ratio | 45.85% | 0% | 0% | 80.46% |
| Debt ratio change over time | -6.52% | 0% | 0% | -0.75% |
| Dept financing | 14% | 0% | 25% | 25% |
| Current Ratio | 4.04% | 0% | 0% | 6.21% |
| Quick Ratio | 3.85% | 0% | 0% | 6.2% |
| Cash Position Ratio | 2.56% | 0% | 0% | 5.92% |
| Liquididy | 26% | 0% | 0% | 75% |
| Short-term ratios | HZNP | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 2.13% | 0% | 0% | -327.32% |
| Return on assets | 1.45% | 0% | 0% | -17.01% |
| Return on sales | 14.28% | 0% | 0% | -23351.25% |
| Return on invested capital | 2.4% | 0% | 0% | -301.3% |
| Profitability | 100% | 0% | 0% | 0% |
| Total debt ratio | 43.71% | 0% | 0% | 105.86% |
| Debt ratio change over time | 19.72% | 0% | 0% | -1.68% |
| Dept financing | 35% | 0% | 0% | 25% |
| Current Ratio | 4.04% | 0% | 0% | 6.21% |
| Quick Ratio | 3.85% | 0% | 0% | 6.2% |
| Cash Position Ratio | 2.56% | 0% | 0% | 5.92% |
| Liquididy | 43% | 0% | 0% | 75% |